Advertisement
Screener

Medifast, Inc. (MED) Marketable Securities, Unrealized Gain (Loss)

Medifast, Inc. Marketable Securities, Unrealized Gain (Loss)

Medifast, Inc. (MED) reported Marketable Securities, Unrealized Gain (Loss) of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.

Discontinued › Income Statement › Other Income

us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2022-11-03

  • Medifast, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2022-09-30 was $0.00.
  • Medifast, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2022-06-30 was -$7.00K.
  • Medifast, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2022-03-31 was $7.00K, a 90.14% decline year-over-year.
  • Medifast, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2021-12-31 was -$16.00K.
  • Medifast, Inc. marketable securities, unrealized gain (loss) for fiscal 2020 was $87.00K, a 141.67% increase from fiscal 2019.
  • Medifast, Inc. marketable securities, unrealized gain (loss) for fiscal 2019 was $36.00K.
  • Medifast, Inc. marketable securities, unrealized gain (loss) for fiscal 2018 was -$236.00K.
Period endMarketable Securities, Unrealized Gain (Loss) 3 monthMarketable Securities, Unrealized Gain (Loss) 6 monthMarketable Securities, Unrealized Gain (Loss) 9 monthMarketable Securities, Unrealized Gain (Loss) 12 month
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
-$7.00K
derived: sum of 2 quarters · filed 2022-11-03
$0.00
10-Q · filed 2022-11-03
-$16.00K
derived: sum of 4 quarters · filed 2022-11-03
2022-06-30-$7.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03
$0.00
10-Q · filed 2022-08-03
-$16.00K
derived: sum of 3 quarters · filed 2022-11-03
-$33.00K
derived: sum of 4 quarters · filed 2022-11-03
2022-03-31$7.00K
10-Q · filed 2022-05-02
-$9.00K
derived: sum of 2 quarters · filed 2022-11-03
-$26.00K
derived: sum of 3 quarters · filed 2022-11-03
-$43.00K
derived: sum of 4 quarters · filed 2022-11-03
2021-12-31-$16.00K
derived: 10-Q 12 month − 10-Q 9 month · filed 2022-11-03
-$33.00K
derived: sum of 2 quarters · filed 2022-11-03
-$50.00K
derived: sum of 3 quarters · filed 2022-11-03
$21.00K
10-Q · filed 2022-11-03
2021-09-30-$17.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
-$34.00K
derived: sum of 2 quarters · filed 2021-11-04
$37.00K
10-Q · filed 2021-11-04
$13.00K
derived: sum of 4 quarters · filed 2022-02-23
2021-06-30-$17.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04
$54.00K
10-Q · filed 2021-08-04
$30.00K
derived: sum of 3 quarters · filed 2022-02-23
$28.00K
derived: sum of 4 quarters · filed 2022-02-23
2021-03-31$71.00K
10-Q · filed 2021-05-04
$47.00K
derived: sum of 2 quarters · filed 2022-02-23
$45.00K
derived: sum of 3 quarters · filed 2022-02-23
2020-12-31-$24.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23
-$26.00K
derived: sum of 2 quarters · filed 2022-02-23
$87.00K
10-K · filed 2022-02-23
2020-09-30-$2.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03
$111.00K
10-Q · filed 2020-11-03
2020-06-30$113.00K
10-Q · filed 2020-08-06
2019-12-31$36.00K
10-K · filed 2021-02-26
2018-12-31-$236.00K
10-K · filed 2020-03-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
COFFEE HOLDING CO INC (JVA)United States$0.023B4.10